Search research articles
Contact Us
Filters
Showing results (201-210 of 247) with videos related to
Page
of 25
Sort By:
Eclinicalmedicine
|
June 14, 2024
Tranexamic acid versus oxytocin prophylaxis in reducing post-partum blood loss, in low-risk pregnant women: TRANOXY STUDY, a phase III randomized clinical trial
Antonio Ragusa, Fernando Ficarola, Amerigo Ferrari, et al.
Journal of Personalized Medicine
|
January 22, 2024
The Utility of CO<sub>2</sub> Laser Treatment of Pelvic Symptoms in Women with Previous Perineal Trauma during Delivery
Maurizio Filippini, Roberto Angioli, Daniela Luvero, et al.
Minerva Ginecologica
|
September 4, 2020
Sentinel lymph node in cervical cancer: a literature review on the use of conservative surgery techniques
Francesco Plotti, Giuseppe Messina, Corrado Terranova, et al.
Journal of Clinical Medicine
|
September 13, 2025
The Role of Deep Neuromuscular Blockade and Sugammadex in Laparoscopic Hysterectomy: A Randomized Controlled Trial
Corrado Terranova, Lorenzo Schiavoni, Francesco Plotti, et al.
International Journal of Molecular Sciences
|
May 23, 2017
Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives
Salvatore Giovanni Vitale, Antonio Simone Laganà, Stella Capriglione, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
April 14, 2012
HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas
Federica Guzzo, Stefania Bellone, Natalia Buza, et al.
Gynecologic Oncology
|
January 10, 2020
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study
Molly Brewer, Roberto Angioli, Giovani Scambia, et al.
Molecular Cancer Therapeutics
|
September 4, 2015
Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo
Salvatore Lopez, Emiliano Cocco, Jonathan Black, et al.
Proteomics
|
October 15, 2014
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy
Maria Isabella Sereni, Elisa Baldelli, Guido Gambara, et al.
Acta Bio-Medica : Atenei Parmensis
|
November 10, 2020
Complications related to in vitro reproductive techniques support the implementation of natural procreative technologies
Aysha Karim Kiani, Stefano Paolacci, Pietro Scanzano, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 247) with videos related to
Sort By:
Page
of 25
Eclinicalmedicine
|
June 14, 2024
Tranexamic acid versus oxytocin prophylaxis in reducing post-partum blood loss, in low-risk pregnant women: TRANOXY STUDY, a phase III randomized clinical trial
Antonio Ragusa, Fernando Ficarola, Amerigo Ferrari, et al.
Journal of Personalized Medicine
|
January 22, 2024
The Utility of CO<sub>2</sub> Laser Treatment of Pelvic Symptoms in Women with Previous Perineal Trauma during Delivery
Maurizio Filippini, Roberto Angioli, Daniela Luvero, et al.
Minerva Ginecologica
|
September 4, 2020
Sentinel lymph node in cervical cancer: a literature review on the use of conservative surgery techniques
Francesco Plotti, Giuseppe Messina, Corrado Terranova, et al.
Journal of Clinical Medicine
|
September 13, 2025
The Role of Deep Neuromuscular Blockade and Sugammadex in Laparoscopic Hysterectomy: A Randomized Controlled Trial
Corrado Terranova, Lorenzo Schiavoni, Francesco Plotti, et al.
International Journal of Molecular Sciences
|
May 23, 2017
Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives
Salvatore Giovanni Vitale, Antonio Simone Laganà, Stella Capriglione, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
April 14, 2012
HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas
Federica Guzzo, Stefania Bellone, Natalia Buza, et al.
Gynecologic Oncology
|
January 10, 2020
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study
Molly Brewer, Roberto Angioli, Giovani Scambia, et al.
Molecular Cancer Therapeutics
|
September 4, 2015
Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo
Salvatore Lopez, Emiliano Cocco, Jonathan Black, et al.
Proteomics
|
October 15, 2014
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy
Maria Isabella Sereni, Elisa Baldelli, Guido Gambara, et al.
Acta Bio-Medica : Atenei Parmensis
|
November 10, 2020
Complications related to in vitro reproductive techniques support the implementation of natural procreative technologies
Aysha Karim Kiani, Stefano Paolacci, Pietro Scanzano, et al.
Page
of 25